Emperra successful with Series B financing

Emperra GmbH E-Health Technologies, a company that Portus assisted with closing its Series A financing three years ago, will receive further growth financing from Robert Bosch Venture Capital GmbH. Including the participation of the two managing partners, the investment amounts to US$ 3.1 Mio. The proceeds will be dedicated to product development and to support Emperra’s growth, especially in the U.S. and in Europe.

Emperra is a medical devices company that develops and distributes telemedical product systems under the brand Evesta for patients that suffer from Diabetes mellitus. The digital solutions ought to secure a fully automatic data collection and documentation, for blood sugar values and insulin units alike. With its medical devices, the start-up aims to provide better patient care and improve their quality of life. Besides, Emperra puts emphasis on mobile applications, using an app for smartphones. The application is thought to be combined with Bluetooth-ready blood glucose meters and sensors for continuous glucose measurement.


Please choose an option. You can find more information about the consequences of your choice via Help.

Select an option to continue

Your selection was saved!



To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept cookies:
    Every cookie like tracking and analytic cookies.
  • Only allow necessary cookies:
    Only cookies from this website.

You can change your cookie setting here anytime: Privacy Policy. Imprint and Disclaimer.